BAXTER INTERNATIONAL INC (BAX) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-03-10

Key Insights

The filing indicates that Joel T. Grade, the Executive Vice President and Chief Financial Officer of Baxter International Inc. (BAX), disposed of 8,153 shares of the company's common stock on March 6, 2026 to cover tax withholding obligations related to the vesting of restricted stock units.
Following the reported transaction, Grade continues to beneficially own 271,674 shares of Baxter International, suggesting he maintains a significant equity stake in the company.
The timing and nature of this insider sale transaction may be worth monitoring, as insider selling can sometimes signal management's sentiment about the company's future prospects.

Want the newest filings?

This analysis covers the filing from 2026-03-10. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-03-10

The reporting person, Reazur Rasul, who holds the position of EVP and Group President of Healthcare at Baxter International Inc. (BAX), has disposed of 12,674 shares of common stock to cover tax withholding obligations on vested restricted stock units.
The disposition of shares represents a relatively small portion (approximately 9%) of the reporting person's total beneficial ownership of 125,557 shares, suggesting no significant change in their overall position in the company.
The timing of the transaction, which occurred on March 6, 2026, is consistent with the settlement of previously granted equity awards, indicating a routine event related to executive compensation.

Filed: 2026-03-10

The reporting person, David S. Rosenbloom, is an Executive Vice President and General Counsel of Baxter International Inc., indicating his importance and influence within the company.
Rosenbloom disposed of 6,620 shares of Baxter's common stock on March 6, 2026, likely to cover tax withholding obligations from the vesting of restricted stock units granted in 2024 and 2025.
Following the reported transaction, Rosenbloom still holds a substantial 138,216 shares of Baxter's common stock, suggesting his continued commitment and alignment with the company's long-term interests.

Filed: 2026-03-10

The reporting person, Maria Cecilia Soriano, is an officer of Baxter International Inc. (BAX), holding the title of Group President, ITT & Pharma.
Soriano disposed of 2,848 shares of Baxter's common stock on March 6, 2026 to cover the withholding of taxes from the vesting of restricted stock units granted in 2024 and 2025.
Following the reported transaction, Soriano continues to beneficially own 75,045 shares of Baxter's common stock directly.

Filed: 2026-03-10

The reporting person, Anita A. Zielinski, who is the SVP, CAO and Controller of Baxter International Inc., has reported a transaction where she forfeited 1,932 shares of common stock to cover withholding taxes, indicating an equity-based compensation event.
The reported transaction occurred on March 6, 2026, suggesting the vesting of restricted stock units granted to the reporting person on March 6, 2025.
The reporting person continues to hold 46,281 shares of Baxter International Inc. common stock following the reported transaction, indicating she maintains a significant equity stake in the company.

Filed: 2026-02-18

The reporting person, Michael R. McDonnell, who is a director of Baxter International Inc. (BAX), received a grant of 1,811 fully vested shares of the company's common stock.
This transaction indicates that a director is taking a long-term position in the company's stock, which could be seen as a positive signal for investors.
The timing of the transaction, occurring on February 13, 2026, suggests the director may have confidence in the company's future performance.

Other reports for BAXTER INTERNATIONAL INC

Current Report Quarterly Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.